{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:57:49Z","timestamp":1791104269130,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.critrevonc.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T17:05:50Z","timestamp":1335027950000},"page":"37-46","source":"Crossref","is-referenced-by-count":41,"title":["Clinical nutrition, body composition and oncology: A critical literature review of the synergies"],"prefix":"10.1016","volume":"84","author":[{"given":"Nathalie","family":"Jacquelin-Ravel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0005","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","article-title":"Cachexia worsens prognosis in patients with resectable pancreatic cancer","volume":"12","author":"Bachmann","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0010","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MCO.0b013e328300ecc1","article-title":"Cachexia: prevalence and impact in medicine","volume":"11","author":"Tan","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.02.001_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0020","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.clnu.2007.03.011","article-title":"Pathophysiology of cancer cachexia: much more than host-tumour interaction?","volume":"26","author":"Skipworth","year":"2007","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.02.001_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","article-title":"Intramyocellular lipid droplets increase with progression of cachexia in cancer patients","volume":"2","author":"Stephens","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clnu.2009.04.024","article-title":"ESPEN guidelines on parenteral nutrition: intensive care","volume":"28","author":"Singer","year":"2009","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.02.001_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/jappl.2000.89.1.81","article-title":"Skeletal muscle mass and distribution in 468 men and women aged 18\u201388 yr","volume":"89","author":"Janssen","year":"2000","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.02.001_bib0050","doi-asserted-by":"crossref","first-page":"E308","DOI":"10.1152\/ajpendo.2000.278.2.E308","article-title":"Metabolically active components of fat free mass and resting energy expenditure in nonobese adults","volume":"278","author":"Illner","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0055","first-page":"155","article-title":"Cancer-induced cachexia: a guide for the oncologist","volume":"7","author":"Gullett","year":"2009","journal-title":"J Soc Integr Oncol"},{"issue":"10","key":"10.1016\/j.critrevonc.2012.02.001_bib0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/oxfordjournals.annonc.a058730","article-title":"Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer","volume":"5","author":"Jebb","year":"1994","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.2008.27273","article-title":"A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands","volume":"89","author":"Lieffers","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.02.001_bib0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1467-789X.2002.00057.x","article-title":"Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies","volume":"3","author":"Muller","year":"2002","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0075","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1054\/clnu.2000.0136","article-title":"Lean body mass changes in cancer patients with weight loss","volume":"19","author":"McMillan","year":"2000","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.critrevonc.2012.02.001_bib0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/CS19990021","article-title":"Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones","volume":"97","author":"Simons","year":"1999","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00075197-199807000-00008","article-title":"Body composition measurements during wasting diseases","volume":"1","author":"Pichard","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.02.001_bib0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.mco.0000165010.31826.3d","article-title":"Dual-energy X-ray absorptiometry and body composition","volume":"8","author":"Plank","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0095","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.02.001_bib0100","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0105","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.52.4.338","article-title":"Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls","volume":"52","author":"Staal-van den Brekel","year":"1997","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.critrevonc.2012.02.001_bib0110","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","article-title":"Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?","volume":"90","author":"Ross","year":"2004","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.02.001_bib0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/gerona\/58.11.M1012","article-title":"Sarcopenia: effects on body composition and function","volume":"58","author":"Roubenoff","year":"2003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.critrevonc.2012.02.001_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000319997","article-title":"Sarcopenia: prevalence, mechanisms, and functional consequences","volume":"37","author":"Berger","year":"2010","journal-title":"Interdiscip Top Gerontol"},{"issue":"5","key":"10.1016\/j.critrevonc.2012.02.001_bib0125","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1152\/japplphysiol.00246.2003","article-title":"Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia","volume":"95","author":"Lauretani","year":"2003","journal-title":"J Appl Physiol"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02982705","article-title":"Sarcopenia: diagnosis and treatment","volume":"12","author":"Morley","year":"2008","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.02.001_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-011-0025-7","article-title":"Myopenia-a new universal term for muscle wasting","volume":"2","author":"Fearon","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.02.001_bib0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"Suppl 3","key":"10.1016\/j.critrevonc.2012.02.001_bib0145","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/sj.ejcn.1601024","article-title":"Sarcopenia and its implications for the elderly","volume":"54","author":"Roubenoff","year":"2000","journal-title":"Eur J Clin Nutr"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0155","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.ijo.0802037","article-title":"Fat-free mass index and fat mass index percentiles in Caucasians aged 18\u201398 y","volume":"26","author":"Schutz","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0160","doi-asserted-by":"crossref","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","article-title":"Skeletal muscle loss: cachexia, sarcopenia, and inactivity","volume":"91","author":"Evans","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.critrevonc.2012.02.001_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MCO.0b013e328340c2c2","article-title":"Cachexia versus sarcopenia","volume":"14","author":"Rolland","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.critrevonc.2012.02.001_bib0170","article-title":"Dynapenia and aging: an update","author":"Manini","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"10.1016\/j.critrevonc.2012.02.001_bib0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.biopha.2007.10.008","article-title":"Overweight\/obesity and cancer genesis: more than a biological link","volume":"61","author":"Irigaray","year":"2007","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0180","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0185","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/oby.2004.107","article-title":"Sarcopenic obesity: the confluence of two epidemics","volume":"12","author":"Roubenoff","year":"2004","journal-title":"Obes Res"},{"issue":"10","key":"10.1016\/j.critrevonc.2012.02.001_bib0190","first-page":"749","article-title":"Estimation of body composition by bioelectrical impedance in cancer patients","volume":"44","author":"Fredrix","year":"1990","journal-title":"Eur J Clin Nutr"},{"issue":"3 Suppl","key":"10.1016\/j.critrevonc.2012.02.001_bib0195","doi-asserted-by":"crossref","first-page":"436S","DOI":"10.1093\/ajcn\/64.3.436S","article-title":"Why bioelectrical impedance analysis should be used for estimating adiposity","volume":"64","author":"Houtkooper","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0200","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1079\/BJN20041292","article-title":"Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer","volume":"92","author":"Gupta","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/j.critrevonc.2012.02.001_bib0205","first-page":"9","article-title":"Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer","volume":"28","author":"Gupta","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2012.02.001_bib0210","article-title":"Standardized phase angle from bioelectrical impedance analysis as prognostic factor for survival in patients with cancer","author":"Paiva","year":"2009","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2012.02.001_bib0215","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.nut.2009.01.015","article-title":"Prognostic significance of bioelectrical impedance phase angle in advanced cancer: preliminary observations","volume":"25","author":"Santarpia","year":"2009","journal-title":"Nutrition"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.02.001_bib0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1049909108330028","article-title":"Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer","volume":"26","author":"Davis","year":"2009","journal-title":"Am J Hosp Palliat Care"},{"issue":"6","key":"10.1016\/j.critrevonc.2012.02.001_bib0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00685883","article-title":"Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile? A review of theoretical and practical considerations","volume":"32","author":"Reilly","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"issue":"9","key":"10.1016\/j.critrevonc.2012.02.001_bib0230","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.1996.14.9.2590","article-title":"Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative","volume":"14","author":"Gurney","year":"1996","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jnci\/82.4.323","article-title":"Is dose normalization to weight or body surface area useful in adults?","volume":"82","author":"Grochow","year":"1990","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.02.001_bib0240","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0245","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1200\/JCO.1998.16.7.2297","article-title":"Body-surface area as a basis for dosing of anticancer agents: science, myth, or habit?","volume":"16","author":"Ratain","year":"1998","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0250","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2165\/00003088-199426040-00005","article-title":"Lean body mass as a predictor of drug dosage. Implications for drug therapy","volume":"26","author":"Morgan","year":"1994","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.critrevonc.2012.02.001_bib0255","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1200\/JCO.1998.16.7.2299","article-title":"Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation","volume":"16","author":"Gurney","year":"1998","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.critrevonc.2012.02.001_bib0260","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/jnci\/djj442","article-title":"Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer","volume":"98","author":"Dignam","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.critrevonc.2012.02.001_bib0265","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2004.07.121","article-title":"Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114","volume":"22","author":"Meyerhardt","year":"2004","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.02.001_bib0270","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.critrevonc.2012.02.001_bib0275","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2012.02.001_bib0280","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2012.02.001_bib0285","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MCO.0b013e3283455d60","article-title":"Quantification of lean tissue losses during cancer and HIV infection\/AIDS","volume":"14","author":"Thibault","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842812000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T13:39:34Z","timestamp":1561642774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842812000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1040842812000200"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2012.02.001","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}